Bleeding management in open heart surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests a method to control bleeding during open heart surgery. It may help you if you are planning to have this surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (non-emergency) open heart surgery
- You have no known bleeding disorders like hemophilia
- You are not on blood-thinning medicine that can't be safely stopped
- You are not on dialysis for kidney failure
- You do not have an active cancer
- You agree to participate and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a blood-clotting test called TEG during certain surgeries in children where bleeding is likely. The goal is to see whether this test helps doctors better manage transfusions (blood or blood products) during and after the operation.
This study tests a special patch called TachoSil against a standard surgical pad (Surgicel) to see which works better for controlling minor oozing during open abdominal, chest, or pelvic surgeries. It may be an option if you are having certain types of surgery and have a small area of mild bleeding that needs help to stop.
This trial compares two treatments (prothrombin complex concentrate and fresh frozen plasma) for managing bleeding during heart surgery. It aims to find which approach works better and is safer for patients.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
Hear when a new Open Heart Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.